Q3 2022 Holdings
Filed 2022-11-14 | 132 holdings | $909.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Boston Scientific Corp(BSX) | COM | 101137107 | $151.0M | 3,898,200 | 16.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $145.6M | 1,717,310 | 16.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $95.2M | 269,700 | 10.5% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $80.5M | 600,000 | 8.9% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $62.8M | 3,196,876 | 6.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $60.0M | 224,600 | 6.6% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $53.5M | 2,800,000 | 5.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $50.1M | 250,500 | 5.5% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $50.1M | 21,960,850 | 5.5% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $43.4M | 2,758,434 | 4.8% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $41.3M | 4,180,768 | 4.5% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $27.5M | 2,871,000 | 3.0% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $16.5M | 5,270,400 | 1.8% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $8.2M | 637,287 | 0.9% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $7.9M | 303,000 | 0.9% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $5.7M | 6,943,654 | 0.6% |
| Amneal Pharmaceuticals Inc(AMRX) | COM STK CL A | 03168L105 | $3.2M | 1,583,490 | 0.4% |
| Acutus MED Inc(AFIB) | COM | 005111109 | $2.3M | 2,648,386 | 0.3% |
| Sinovac Biotech LTD(SVA) | SHS | P8696W104 | $340.5K | 2,718,735 | 0.0% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $183.8K | 2,584,900 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $169.2K | 348,700 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $157.7K | 5,525,926 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $143.3K | 14,567,176 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $134.9K | 267,200 | 0.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $113.7K | 2,599,000 | 0.0% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $109.6K | 5,779,071 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $108.1K | 373,200 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $107.7K | 10,280,947 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $107.3K | 572,700 | 0.0% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $105.9K | 7,447,140 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $104.3K | 762,600 | 0.0% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $102.6K | 202,200 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $101.5K | 918,500 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $99.1K | 1,418,892 | 0.0% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $98.8K | 17,041,668 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $95.2K | 896,545 | 0.0% |
| Stryker Corporation(SYK) | COM | 863667101 | $85.7K | 423,100 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $79.8K | 966,300 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $78.1K | 6,563,077 | 0.0% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $71.7K | 1,994,717 | 0.0% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $66.4K | 10,039,691 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $66.0K | 1,505,153 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $63.2K | 1,679,417 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $60.9K | 9,011,437 | 0.0% |
| Ikena Oncology Inc | NONVOTING | 000000000 | $60.5K | 12,147,877 | 0.0% |
| Si-Bone Inc(SIBN) | COM | 825704109 | $58.8K | 3,368,000 | 0.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $58.2K | 5,694,841 | 0.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $53.4K | 992,400 | 0.0% |
| Xtant MED Hldgs Inc(XTNT) | COM NEW | 98420P308 | $52.6K | 73,114,592 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $49.0K | 4,634,900 | 0.0% |